These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 25802011)

  • 1. The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
    Mallucci G; Peruzzotti-Jametti L; Bernstock JD; Pluchino S
    Prog Neurobiol; 2015 Apr; 127-128():1-22. PubMed ID: 25802011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Leukocentric Theory of Neurological Disorder: A Manifesto.
    Fern R
    Neurochem Res; 2017 Sep; 42(9):2666-2672. PubMed ID: 28444635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis.
    Tsouki F; Williams A
    Stem Cells; 2021 Aug; 39(8):993-1007. PubMed ID: 33754376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cortical gray matter lesions in multiple sclerosis].
    Kawachi I; Nishizawa M
    Brain Nerve; 2015 Apr; 67(4):497-504. PubMed ID: 25846598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.
    Robinson RR; Dietz AK; Maroof AM; Asmis R; Forsthuber TG
    Immunotherapy; 2019 Feb; 11(2):129-147. PubMed ID: 30730270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes lure CXCR2-expressing CD4
    Khaw YM; Tierney A; Cunningham C; Soto-Díaz K; Kang E; Steelman AJ; Inoue M
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33597297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
    Kawachi I; Nishizawa M
    Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.
    Howell OW; Schulz-Trieglaff EK; Carassiti D; Gentleman SM; Nicholas R; Roncaroli F; Reynolds R
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):798-813. PubMed ID: 25421634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic synaptic pathology in multiple sclerosis gray matter.
    Vercellino M; Marasciulo S; Grifoni S; Vallino-Costassa E; Bosa C; Pasanisi MB; Crociara P; Casalone C; Chiò A; Giordana MT; Corona C; Cavalla P
    Mult Scler; 2022 Mar; 28(3):369-382. PubMed ID: 34124960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the origins of grey matter damage in multiple sclerosis.
    Calabrese M; Magliozzi R; Ciccarelli O; Geurts JJ; Reynolds R; Martin R
    Nat Rev Neurosci; 2015 Mar; 16(3):147-58. PubMed ID: 25697158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
    Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
    J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsing and progressive forms of multiple sclerosis: insights from pathology.
    Dutta R; Trapp BD
    Curr Opin Neurol; 2014 Jun; 27(3):271-8. PubMed ID: 24722325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
    Jürgens T; Jafari M; Kreutzfeldt M; Bahn E; Brück W; Kerschensteiner M; Merkler D
    Brain; 2016 Jan; 139(Pt 1):39-46. PubMed ID: 26667278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology.
    Teuber-Hanselmann S; Meinl E; Junker A
    J Pathol; 2020 Apr; 250(5):496-509. PubMed ID: 32073139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
    Loveless S; Neal JW; Howell OW; Harding KE; Sarkies P; Evans R; Bevan RJ; Hakobyan S; Harris CL; Robertson NP; Morgan BP
    Brain Pathol; 2018 Jul; 28(4):507-520. PubMed ID: 28707765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.